nach oben

Neurological Sciences

Erschienen in:

09.06.2022 | Original Article

Cross-cultural adaptation, validation, and the reliability of the Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis

verfasst von: Fatih Özden, Mehmet Özkeskin, Nur Yüceyar

Erschienen in: Neurological Sciences | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Examining sleep-related behavioral disorder strategies in detail for MS patients provides an essential assessment to address specific disease findings. The aim of the study was to demonstrate the reliability and validity of the Turkish Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis (MS).

Methods

A total of 100 MS patients were filled Sleep-Related Behaviors Questionnaire (SRBQ), Beck Depression Inventory (BDI), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI). One week later, 30 randomly selected patients were refilled the SRBQ. The test–retest reliability, internal consistency, and contruct validity were determined.

Results

The mean age of the individuals included in the study was 38.9 ± 11.0 years. The ICC value of the reproducibility of SRBQ was calculated as 0.877 (CI: 0.74–0.94). The test–retest reliability of the SRBQ was excellent (ICC > 0.80). Cronbach’s alpha value of the SRBQ was 0.877, which indicates excellent consistency. The SRBQ had correlation coefficients of 0.573, 0.509, and 0.523 with ISI, PSQI, and BDI, respectively. The SRBQ had high validity (r > 0.50, p < 0.01).

Conclusion

The Turkish SRBQ was found to be valid and reliable in patients with MS. Owing to the long but comprehensive nature of the SRBQ, a low-cost detailed measurement could be obtained in clinical practice.

Pokryszko-Dragan A, Bilińska M, Gruszka E, Biel Ł, Kamińska K, Konieczna K (2013) Sleep disturbances in patients with multiple sclerosis. Neurol Sci 34(8):1291–1296CrossRef

Bamer A, Johnson K, Amtmann D, Kraft G (2008) Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler J 14(8):1127–1130CrossRef

Merlino G, Fratticci L, Lenchig C, Valente M, Cargnelutti D, Picello M, Serafini A, Dolso P, Gigli G (2009) Prevalence of ‘poor sleep’among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med 10(1):26–34CrossRef

Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr K-M, Bø L (2012) Poor sleep in patients with multiple sclerosis. PLoS ONE 7(11):e49996CrossRef

Garland SN, Scurrey SR, Ploughman M (2017) Factors associated with poor sleep in older adults with multiple sclerosis. Int J Behav Med 24(6):937–945CrossRef

Sakkas GK, Giannaki CD, Karatzaferi C, Manconi M (2019) Sleep abnormalities in multiple sclerosis. Curr Treat Options Neurol 21(1):4CrossRef

Taphoorn M, Van Someren E, Snoek F, Strijers R, Swaab D, Visscher F, De Waal L, Polman C (1993) Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol 240(7):446–448CrossRef

Irwin MR, Wang M, Ribeiro D, Cho HJ, Olmstead R, Breen EC, Martinez-Maza O, Cole S (2008) Sleep loss activates cellular inflammatory signaling. Biol Psychiat 64(6):538–540CrossRef

10.

Melamud L, Golan D, Luboshitzky R, Lavi I, Miller A (2012) Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis. J Neurol Sci 314(1–2):37–40CrossRef

11.

Kaminska M, Kimoff R, Schwartzman K, Trojan D (2011) Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction. J Neurol Sci 302(1–2):7–13CrossRef

12.

Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4(5):487–504CrossRef

13.

Hughes AJ, Dunn KM, Chaffee T (2018) Sleep disturbance and cognitive dysfunction in multiple sclerosis: a systematic review. Curr Neurol Neurosci Rep 18(1):1–9CrossRef

14.

Amtmann D, Bamer AM, Kim J, Chung H, Salem R (2018) People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures. Disabil Health J 11(1):99–107CrossRef

15.

Riachi N, Ahdab R, Challah MA, Creange A, Lefaucheur J-P, Ayache SS (2015) Fatigue in multiple sclerosis

16.

Braley TJ, Boudreau EA (2016) Sleep disorders in multiple sclerosis. Curr Neurol Neurosci Rep 16(5):50CrossRef

17.

Ree MJ, Harvey AG (2004) Investigating safety behaviours in insomnia: the development of the Sleep-Related Behaviours Questionnaire (SRBQ). Behav Chang 21(1):26–36CrossRef

18.

Lebrun C, Gély-Nargeot M-C, Maudarbocus KH, Bayard S (2018) Assessing sleep-related safety behaviors: adaptation and validation of a french version of the sleep-related behaviors questionnaire in a nonclinical sample. Behav Sleep Med

19.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25(24):3186–3191CrossRef

20.

Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46(12):1417–1432CrossRef

21.

Faul F, Erdfelder E, Buchner A, Lang A-G (2009) Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behavior research methods 41 (4):1149–1160

22.

Faul F, Erdfelder E, Lang A-G, Buchner A (2007) G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191CrossRef

23.

Walter S, Eliasziw M, Donner A (1998) Sample size and optimal designs for reliability studies. Stat Med 17(1):101–110CrossRef

24.

Bonett DG (2002) Sample size requirements for estimating intraclass correlations with desired precision. Stat Med 21(9):1331–1335CrossRef

25.

Hisli N (1989) The validity and reliability of Beck Depression Inventory for university students. Psikoloji dergisi 7:3–13

26.

Boysan M, Gulec M, Besiroglu L, Kalafat T (2010) Psychometric properties of the Insomnia Severity Index in Turkish sample

27.

Ağargün MY, Kara H, Anlar Ö (1996) The validity and reliability of the Pittsburgh Sleep Quality Index. Turk Psikiyatri Derg 7(2):107–115

28.

Juniper EF (1996) How to develop and validate a new health-related quality of life instrument. Quality of life and pharamacoeconomics in clinical trials:49–56

29.

Baumgartner TA, Chung H (2001) Confidence limits for intraclass reliability coefficients. Meas Phys Educ Exerc Sci 5(3):179–188CrossRef

30.

Portney LG, Watkins MP (2009) Foundations of clinical research: applications to practice, vol 892. Pearson/Prentice Hall Upper Saddle River, NJ

31.

Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42CrossRef

32.

Hamilton N, Freche R, Zhang Y, Zeller G, Carroll I (2021) Test anxiety and poor sleep: a vicious cycle. Int J Behav Med 28(2):250–258CrossRef

33.

Regier DA, Kuhl EA, Kupfer DJ (2013) The DSM-5: classification and criteria changes. World Psychiatry 12(2):92–98CrossRef

Titel: Cross-cultural adaptation, validation, and the reliability of the Sleep-Related Behaviors Questionnaire in patients with multiple sclerosis
verfasst von: Fatih Özden
Mehmet Özkeskin
Nur Yüceyar
Publikationsdatum: 09.06.2022
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 9/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06196-4

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2022

Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention

The association between onabotulinumtoxinA and anti-CGRP monoclonal antibodies: a reliable option for the optimal treatment of chronic migraine

Experimental animal models of migraine

The putative role of trigemino-vascular system in brain perfusion homeostasis and the significance of the migraine attack

Myelodysplastic syndrome in an alemtuzumab-treated multiple sclerosis patient

OPTN variants in ALS cases: a case report of a novel mutation and literature review